Form 4: Dentsply Sirona Director Acquires Phantom Stock Through Deferred Compensation Plan

Jonathan Jay Mazelsky, a director at Dentsply Sirona Inc. (XRAY), acquired phantom stock equivalent to 1,687.2548 shares of common stock through the directors' deferred compensation plan on March 31, 2025.

Summary

• On March 31, 2025, Jonathan Jay Mazelsky, a director of Dentsply Sirona Inc., acquired 1,687.2548 shares of phantom stock through the company's directors' deferred compensation plan.
• Each share of phantom stock is equivalent to one share of Dentsply Sirona common stock.
• The phantom stock becomes payable in common stock upon the director's termination of service.
• Following the transaction, Mazelsky beneficially owns 7,522.8547 shares of phantom stock.
• The price of the phantom stock was $14.82 per share.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a standard director compensation practice that aligns interests with shareholders.

Positives

• The acquisition of phantom stock aligns the director's interests with the long-term performance of the company.
• Deferred compensation plans can be tax-efficient for directors.

Future Outlook

The phantom stock will be converted to common stock upon the director's termination of service.

Industry Context

Director compensation through equity-based awards like phantom stock is a common practice in publicly traded companies to incentivize and align the interests of directors with shareholders.

Comparison to Industry Standards

• Many companies in the dental and medical device industry, such as Align Technology and Straumann, utilize deferred compensation plans and equity-based awards for their directors.
• The specific terms and amounts of these awards vary based on company size, performance, and individual director contributions.
• Phantom stock is a common tool used to defer compensation and align director interests with shareholder value.

Stakeholder Impact

• The acquisition of phantom stock has a minimal direct impact on stakeholders.
• It reinforces the alignment of director interests with shareholder value.

Key Dates

Keywords

Dentsply Sirona, XRAY, Form 4, Director, Jonathan Jay Mazelsky, Phantom Stock, Deferred Compensation, Beneficial Ownership, SEC Filing